View Author
patient resistance treatment therapy hepatitis hepatitis b study hepatology level month response combination hbv dna ef ficacy combination therapy baseline hbv dna levels monotherapy tenofovir virus tdf monotherapy genotypic hbeag range tdf treatment liver genotypic resistance entecavir lamivudine adefovir analysis virological mutation virological response hepatitis b virus serum ficacy na-na lam resistance na-na ıve patients germany etv monotherapy follow-up week 48 table department probability hepatology 2012 vol hbsag disease virological breakthrough liver disease cirrhosis gastroenterology tenofovir disoproxil fumarate rescue therapy breakthrough adv resistance genotypic adv resistance signi treatment adaptation cohort bristol-myers squibb bommel failure baseline hbv dna lactic acidosis observation period presence safety week 48. effect na-experienced infection nucleo adefovir dipivoxil variant interquartile range na-experienced patients virologic response
4 Most Recent Publications
|
Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis
(Article)
Zoutendijk, R. Reijnders, J.G.P. Berg, T. Hansen, B.E. Sonneveld, M.J. Wedemeyer, H. Janssen, H.L.A. Zoulim, F. Brown, A. Mutimer, D.J. Deterding, K. Hofmann, W.P. Petersen, J. Fasano, M. Buti, M. |
2013-05-01
|
|
Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: An international multicenter cohort study
(Article)
Petersen, J. Ratziu, V. Berg, T. Sarrazin, C. Lutgehetmann, M. Buggisch, P. Buti, M. Janssen, H.L.A. Brown, A. Lampertico, P. Schollmeyer, J. Zoulim, F. Wedemeyer, H. Sterneck, M. |
2012-03-01
|
|
Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naïve patients with a partial virological response
(Article)
Zoutendijk, R. Reijnders, J.G.P. Bömmel, F. van Pradat, P. Oo, Y. Luetgehetmann, M. Berg, T. Hansen, B.E. Wedemeyer, H. Janssen, H.L.A. Brown, A. Zoulim, F. Mutimer, D. Deterding, K. Petersen, J. Hofmann, W.P. Buti, M. Santantonio, T. |
2011-08-01
|
|
Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues
(Article)
Bömmel, F. van Man, R.A. de Sarrazin, C. Böcher, W.O. Spengler, U. Wasmuth, H.E. Reinders, J.G.P. Möller, B. Rhode, P. Feucht, H.H. Wiedenmann, B. Berg, T. Wedemeyer, H. Deterding, K. Petersen, J. Buggisch, P. Erhardt, A. Hüppe, D. Stein, K. Trojan, J. |
2010-01-01
|
